🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
The study was designed to obtain data about the efficacy and safety of 3 do...
Status
Completed
Location
Novartis Investigative site
Start Date
2006-12
Trial ID
NCT00403845
Treatments Being Tested
This surveillance was designed as a prospective, open-label, multicenter, s...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2022-05-09
Trial ID
NCT05217810
This study is a randomized, double-blind, placebo-controlled, three-period ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-05
Trial ID
NCT03257995
Treatments Being Tested
This study assessed the efficacy, safety, tolerability, and pharmacokinetic...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-10
Trial ID
NCT01012739
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00846586
Treatments Being Tested
The purpose of this study is to compare treatment with QVM149, an inhaler t...
Status
Withdrawn
Location
Robarts Research Insitute; The University of Western Ontario; London Health Sciences Centre
Start Date
2021-12-01
Trial ID
NCT04206761
Treatments Being Tested
The purpose of the trial was to evaluate the efficacy and safety of two dif...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-12-08
Trial ID
NCT02571777
Treatments Being Tested
This study will evaluate the onset of action of indacaterol (150 and 300 µg...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-04
Trial ID
NCT00669617
This study evaluated the safety and efficacy of 26 weeks treatment with ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-11
Trial ID
NCT00567996
Treatments Being Tested